MedPath

The Role of a Motion Sensor With Accompanying Web Application on Step Counts, Energy Balance, and Metabolic Markers in Nurses

Not Applicable
Completed
Conditions
Cardiovascular Risk Factor
Cardiovascular Diseases
Interventions
Behavioral: Motion sensor
Registration Number
NCT04524572
Lead Sponsor
Ottawa Heart Institute Research Corporation
Brief Summary

The purpose of this prospective randomized controlled trial is to explore the role of a motion sensor with accompany web application on step counts, energy balance, and metabolic markers in nurses. Additionally, eating behaviours, behavioural regulation in exercise, and mood states that may impact these parameters will also be examined.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
76
Inclusion Criteria
    1. Participant must be a registered nurse with the University of Ottawa Heart Institute;

    2. Participant must be 18 years of age or older;

    3. Participant must be able to walk unassisted;

    4. Participant is able and willing to provide informed consent.

Exclusion Criteria
  1. Participant is pregnant, lactating or planning to become pregnant during the study period;
  2. Participant is unable to read and understand English;
  3. Medical contraindications to exercise;
  4. Already using a motion sensor device to track physical activity. -

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Individual ChallengeMotion sensorParticipants will be able to log onto their Tractivity® Online web account at any time during the 4-week intervention phase to track their daily step counts and physical activity expenditure
Team challengeMotion sensorparticipants will be able to log onto their Tractivity® Online web account at any time during the 4-week intervention phase to track their teams' daily step counts and physical activity expenditure in comparison to the group average of other teams.
friend challengeMotion sensorParticipants will be able to log onto their Tractivity® Online web account at any time during the 4-week intervention phase to track their daily step counts and physical activity expenditure in comparison to the group average of all participants randomized to the friend challenge.
Primary Outcome Measures
NameTimeMethod
Step counts6 weeks during observation and 6 weeks during intervention

All participants will be asked to wear a Tractivity® motion sensor device on their ankle for to assess their daily step count and physical activity energy expenditure

Secondary Outcome Measures
NameTimeMethod
Body Mass (kg)Screening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52

Body weight will be measured using a digital scale to the nearest 0.1 kilogram

Waist CircumferenceScreening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52

Waist circumference will be measured using a tape measure

Fat massScreening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52

Fat mass will be measured using bioelectrical impedance analysis

Trial Locations

Locations (1)

University of Ottawa Heart Institute

🇨🇦

Ottawa, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath